10x Genomics is trading at $93.97, up 4.37%, amid strong orders for its newly launched Atera system. - Commercial Atera shipments began September 29; booked orders exceed the 40 instruments expected to ship in 2026. - Reuters reported early institutional customers and broad biopharma interest; reports did not explicitly attribute the gain to the launch. - The broader market was modestly positive, with index moves below 0.5%; shares climbed from $75.62 on September 23 to $90.04 on September 29.